Search results
The American Diabetes Association Highlights Innovations in New Drug Therapies for Patients with...
FOX 59 Indianapolis· 1 day agoThe data was presented as a late-breaking poster and oral presentations, respectively at the American Diabetes Association® (ADA) 84th ...
Ozempic® (semaglutide) injection 1 mg demonstrated reduction in risk of kidney disease-related...
Benzinga· 9 hours agoSemaglutide 1 mg demonstrated a statistically significant and superior reduction of 24% in the risk of kidney disease-related events vs. placebo in adults with type 2 diabetes and chronic kidney disease.Based on FLOW
...DPN 1 Phase 2 Study of LX9211 Published Today in Diabetes Care, a Peer-Reviewed Journal of the ...
Morningstar· 6 days agoLexicon Pharmaceuticals, Inc. (Nasdaq: LXRX) today announced that Diabetes Care, the peer-reviewed journal of the American Diabetes & ...
NUTRITION 2024 Press Materials Available Now | Newswise
Newswise· 22 hours agoPress materials are now available for NUTRITION 2024, the annual flagship meeting of the American Society for Nutrition (ASN). Top nutrition scientists and
Eli Lilly seeks FDA’s OK to expand Zepbound’s uses to include sleep apnea
Market Watch· 3 days agoFor more than half of patients who use the common sleep-apnea therapy PAP, or positive airway...
Inhaled Insulin Could Help Folks With Type 1 Diabetes Avoid Needles
US News & World Report· 17 hours agoInhaled insulin could be a better option than injections or pumps for some patients with type 1 diabetes, a new clinical trial shows. Patients using inhaled insulin (Afrezza ...
Obesity drugs from Altimmune, Hengrui show potential; Lilly details Zepbound sleep apnea data
BioPharma Dive via Yahoo Finance· 14 hours agoToday, a brief rundown of news from Altimmune, Jiangsu Hengrui, Eli Lilly and others that you might...
Experts Advise on Early-Risk Monitoring for Type 1 Diabetes
Medscape· 22 hours agoA new international consensus statement offers guidance for primary care and endocrinology providers...
Biotechs Race to Develop New Treatments as Global Pancreatic Cancer Market Size Expected to Reach...
Morningstar· 5 days agoPALM BEACH, Fla., June 20, 2024 (GLOBE NEWSWIRE) -- FN Media Group News Commentary - Pancreatic cancer is among the most frequently diagnosed and the seventh leading cause of cancer death globally. Pancreatic cancer becomes more common in the Western
Trial: Fenofibrate Slows Diabetic Retinopathy Progression
Medscape· 2 days agoThe old, generic cholesterol drug fenofibrate has shown potential for slowing the progression of...